13F-HR filed by Pfizer Inc
Pfizer Inc filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-12 13:00:17 UTC, with 17 holding rows worth $164,248,920.
- Accession
- 0000078003-26-000135
- Filer
- CIK 78003
- Filed
- 2026-11-12
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 20 entries on the cover page, a total value of $164,248,920 stated on the cover page (in dollars after the unit check, H1), rows summing to $164,248,920 with VALUE read as dollars as filed, 13F file number 028-25239. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 22,032,040 | $36,352,866 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 3,457,815 | $26,244,816 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 295,652 | $23,510,247 | dollars as filed | |
| AGOMAB THERAPEUTICS NV | 00860C102 | SPONSORED ADS | 2,151,213 | $22,609,249 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 7,032,770 | $20,113,722 | dollars as filed | |
| Wave Life Sciences Inc. | 94352A104 | COM | 1,875,000 | $7,087,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 505,645 | $6,568,329 | dollars as filed | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 4,690,431 | $5,816,134 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 372,904 | $4,907,417 | dollars as filed | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 2,411,575 | $2,990,353 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 2,362,348 | $2,905,688 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 953,834 | $2,575,352 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 538,841 | $2,176,918 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 44,357 | $225,334 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702203 | COM NEW | 31,305 | $112,072 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 2,928 | $31,213 | dollars as filed | |
| SENSEONICS HOLDINGS INC | 81727U303 | COMMON STOCK | 2,171 | $21,710 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000078003-26-000135 | this filing | 2026-11-12 |